Closing arguments have been made in the first Actos bladder cancer lawsuit to go to trial. The plaintiff’s counsel told jurors that Takeda’s internal company e-mails confirm that the Japanese drug maker hid Actos bladder cancer risks from the public in order to increase its profits. The 79-year-old plaintiff, now dying of bladder cancer after […]